The neurochemical profile quantified by in vivo 1H NMR spectroscopy

[1]  R. Gruetter,et al.  N-Acetylcysteine Normalizes Neurochemical Changes in the Glutathione-Deficient Schizophrenia Mouse Model During Development , 2012, Biological Psychiatry.

[2]  R. Gruetter,et al.  Cerebral Glutamine Metabolism under Hyperammonemia Determined in vivo by Localized 1H and 15N NMR Spectroscopy , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[3]  Tongbin Li,et al.  Cortical Metabolites as Biomarkers in the R6/2 Model of Huntington's Disease , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[4]  Malte F. Alf,et al.  High‐resolution spatial mapping of changes in the neurochemical profile after focal ischemia in mice , 2012, NMR in biomedicine.

[5]  Jetse S van Gorp,et al.  High‐field MRS of the human brain at short TE and TR , 2011, NMR in biomedicine.

[6]  Bettina Kulle,et al.  Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas. , 2011, European journal of radiology.

[7]  D. Matsuzawa,et al.  Magnetic resonance spectroscopy study of the antioxidant defense system in schizophrenia. , 2011, Antioxidants & redox signaling.

[8]  K. Bushara,et al.  Distinct Neurochemical Profiles of Spinocerebellar Ataxias 1, 2, 6, and Cerebellar Multiple System Atrophy , 2011, The Cerebellum.

[9]  Gülin Öz,et al.  Short‐echo, single‐shot, full‐intensity proton magnetic resonance spectroscopy for neurochemical profiling at 4 T: Validation in the cerebellum and brainstem , 2011, Magnetic resonance in medicine.

[10]  Rolf Gruetter,et al.  Early Predictive Biomarkers for Lesion After Transient Cerebral Ischemia , 2011, Stroke.

[11]  Rolf Gruetter,et al.  Diffusion tensor echo planar imaging using surface coil transceiver with a semiadiabatic RF pulse sequence at 14.1T , 2011, Magnetic resonance in medicine.

[12]  R. Gruetter,et al.  Longitudinal MR assessment of hypoxic ischemic injury in the immature rat brain , 2011, Magnetic resonance in medicine.

[13]  D. Ellison,et al.  Infiltrative cerebellar ganglioglioma: conventional and advanced MRI, proton MR spectroscopic, and FDG PET findings in an 18-month-old child. , 2011, Clinical radiology.

[14]  K. Uğurbil,et al.  Enhanced neurochemical profile of the rat brain using in vivo 1H NMR spectroscopy at 16.4 T , 2011, Magnetic resonance in medicine.

[15]  R. Gruetter,et al.  Neurochemical profile of the developing mouse cortex determined by in vivo1H NMR spectroscopy at 14.1 T and the effect of recurrent anaesthesia , 2010, Journal of neurochemistry.

[16]  M. D'Amour,et al.  MRS study of the effects of minocycline on markers of neuronal and microglial integrity in ALS. , 2010, Magnetic resonance imaging.

[17]  R. Gruetter,et al.  Direct in vivo measurement of glycine and the neurochemical profile in the rat medulla oblongata , 2010, NMR in biomedicine.

[18]  I. Tkáč,et al.  Region‐specific changes in ascorbate concentration during rat brain development quantified by in vivo 1H NMR spectroscopy , 2010, NMR in biomedicine.

[19]  K. Bushara,et al.  1H MR spectroscopy in Friedreich's ataxia and ataxia with oculomotor apraxia type 2 , 2010, Brain Research.

[20]  T. Scheenen,et al.  31P Magnetic resonance spectroscopic imaging with polarisation transfer of phosphomono‐ and diesters at 3 T in the human brain: relation with age and spatial differences , 2010, NMR in biomedicine.

[21]  I. Ferreira,et al.  Multiple Defects in Energy Metabolism in Alzheimers Disease , 2010 .

[22]  Peter Andersen,et al.  In vivo 1H NMR spectroscopy of the human brain at 9.4 T: initial results. , 2010, Journal of magnetic resonance.

[23]  A. Doerfler,et al.  Alterations of intracerebral γ‐aminobutyric acid (GABA) levels by titration with levetiracetam in patients with focal epilepsies , 2010, Epilepsia.

[24]  R. Gruetter,et al.  1H‐[13C] NMR spectroscopy of the rat brain during infusion of [2‐13C] acetate at 14.1 T , 2010, Magnetic resonance in medicine.

[25]  Hoby P Hetherington,et al.  Improved homogeneity of the transmit field by simultaneous transmission with phased array and volume coil , 2010, Journal of magnetic resonance imaging : JMRI.

[26]  J. Verbalis.  Brain volume regulation in response to changes in osmolality , 2010, Neuroscience.

[27]  K. Bushara,et al.  Neurochemical alterations in spinocerebellar ataxia type 1 and their correlations with clinical status , 2010, Movement disorders : official journal of the Movement Disorder Society.

[28]  Rolf Gruetter,et al.  Neurochemical profile of the mouse hypothalamus using in vivo 1H MRS at 14.1T , 2010, NMR in biomedicine.

[29]  F. Durif,et al.  Metabolic changes detected in vivo by 1H MRS in the MPTP‐intoxicated mouse , 2010, NMR in biomedicine.

[30]  I. Akiguchi,et al.  Absolute Quantification in Proton Magnetic Resonance Spectroscopy Is Useful to Differentiate Amnesic Mild Cognitive Impairment from Alzheimer’s Disease and Healthy Aging , 2010, Dementia and Geriatric Cognitive Disorders.

[31]  B. Jenkins,et al.  Anti-inflammatory treatment in AD mice protects against neuronal pathology , 2010, Experimental Neurology.

[32]  J. Lauriello,et al.  1H-MRS at 4 Tesla in minimally treated early schizophrenia , 2010, Molecular Psychiatry.

[33]  T. Scheenen,et al.  In vivo 13C magnetic resonance spectroscopy of a human brain tumor after application of 13C-1-enriched glucose. , 2010, Magnetic resonance imaging.

[34]  J. Oliveira.  Mitochondrial bioenergetics and dynamics in Huntington’s disease: tripartite synapses and selective striatal degeneration , 2010, Journal of bioenergetics and biomembranes.

[35]  H. Lei,et al.  Functional changes in the frontal cortex in Parkinson’s disease using a rat model , 2010, Journal of Clinical Neuroscience.

[36]  D. Dobrota,et al.  Proton magnetic resonance spectroscopy in patients with early stages of amyotrophic lateral sclerosis , 2010, Neuroradiology.

[37]  Jong H. Yoon,et al.  GABA Concentration Is Reduced in Visual Cortex in Schizophrenia and Correlates with Orientation-Specific Surround Suppression , 2010, The Journal of Neuroscience.

[38]  Dinesh K. Deelchand,et al.  Noninvasive Detection of Presymptomatic and Progressive Neurodegeneration in a Mouse Model of Spinocerebellar Ataxia Type 1 , 2010, The Journal of Neuroscience.

[39]  Tyrone D. Cannon,et al.  Proton MRS in twin pairs discordant for schizophrenia , 2010, Molecular Psychiatry.

[40]  Jing Han,et al.  Study of the features of proton MR spectroscopy (1H‐MRS) on amyotrophic lateral sclerosis , 2010, Journal of magnetic resonance imaging : JMRI.

[41]  S. Mueller,et al.  (1)H MRS detection of glycine residue of reduced glutathione in vivo. , 2010, Journal of magnetic resonance.

[42]  D. Matsuzawa,et al.  Specific metabolites in the medial prefrontal cortex are associated with the neurocognitive deficits in schizophrenia: A preliminary study , 2010, NeuroImage.

[43]  R. Gruetter,et al.  Deep thiopental anesthesia alters steady‐state glucose homeostasis but not the neurochemical profile of rat cortex , 2010, Journal of neuroscience research.

[44]  G. Krueger,et al.  Eddy current effects on a clinical 7T-68 cm bore scanner , 2010, Magnetic Resonance Materials in Physics, Biology and Medicine.

[45]  F. Zang,et al.  Role of Myo-Inositol by Magnetic Resonance Spectroscopy in Early Diagnosis of Alzheimer’s Disease in APP/PS1 Transgenic Mice , 2010, Dementia and Geriatric Cognitive Disorders.

[46]  C. Arús,et al.  1H‐MRSI pattern perturbation in a mouse glioma: the effects of acute hyperglycemia and moderate hypothermia , 2010, NMR in biomedicine.

[47]  Jullie W Pan,et al.  RF shimming for spectroscopic localization in the human brain at 7 T , 2010, Magnetic resonance in medicine.

[48]  Carola Seifried,et al.  Phosphorus and proton magnetic resonance spectroscopy demonstrates mitochondrial dysfunction in early and advanced Parkinson's disease. , 2009, Brain : a journal of neurology.

[49]  R. Gruetter,et al.  Caffeine consumption attenuates neurochemical modifications in the hippocampus of streptozotocin‐induced diabetic rats , 2009, Journal of neurochemistry.

[50]  Yan Zhang,et al.  Automatic high‐order shimming using parallel columns mapping (PACMAP) , 2009, Magnetic resonance in medicine.

[51]  Rolf Gruetter,et al.  Comparison of T1 relaxation times of the neurochemical profile in rat brain at 9.4 tesla and 14.1 tesla , 2009, Magnetic resonance in medicine.

[52]  K. Uğurbil,et al.  In vivo 1H NMR spectroscopy of the human brain at high magnetic fields: Metabolite quantification at 4T vs. 7T , 2009, Magnetic resonance in medicine.

[53]  P. Teismann,et al.  Glutathione—a review on its role and significance in Parkinson's disease , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[54]  J. Larsen,et al.  Vitamin C deficiency in early postnatal life impairs spatial memory and reduces the number of hippocampal neurons in guinea pigs. , 2009, The American journal of clinical nutrition.

[55]  Kelvin O. Lim,et al.  Neurochemical changes in the rat prefrontal cortex following acute phencyclidine treatment: an in vivo localized 1H MRS study , 2009, NMR in biomedicine.

[56]  J. Mulder,et al.  GABA action in immature neocortical neurons directly depends on the availability of ketone bodies , 2009, Journal of neurochemistry.

[57]  Steven Warach,et al.  Measurement of glutathione in normal volunteers and stroke patients at 3T using J‐difference spectroscopy with minimized subtraction errors , 2009, Journal of magnetic resonance imaging : JMRI.

[58]  Heinrich Lanfermann,et al.  Conversion to dementia in mild cognitive impairment is associated with decline of N-actylaspartate and creatine as revealed by magnetic resonance spectroscopy , 2009, Psychiatry Research: Neuroimaging.

[59]  Rolf Gruetter,et al.  Neuroprotective Role of Lactate after Cerebral Ischemia , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[60]  M. Mascalchi,et al.  Impact of cerebrospinal fluid contamination on brain metabolites evaluation with 1H‐MR spectroscopy: A single voxel study of the cerebellar vermis in patients with degenerative ataxias , 2009, Journal of magnetic resonance imaging : JMRI.

[61]  M. Castro,et al.  A metabolic switch in brain: glucose and lactate metabolism modulation by ascorbic acid , 2009, Journal of neurochemistry.

[62]  R. Gruetter,et al.  Steady-State Brain Glucose Transport Kinetics Re-Evaluated with a Four-State Conformational Model , 2009, Front. Neuroenerg..

[63]  J. Kwon,et al.  Proton magnetic resonance spectroscopy in subjects with high genetic risk of schizophrenia: Investigation of anterior cingulate, dorsolateral prefrontal cortex and thalamus , 2009, Schizophrenia Research.

[64]  Rolf Gruetter,et al.  MR spectroscopy of the human brain with enhanced signal intensity at ultrashort echo times on a clinical platform at 3T and 7T , 2009, Magnetic resonance in medicine.

[65]  F Träber,et al.  A multicenter 1H-MRS study of the medial temporal lobe in AD and MCI , 2009, Neurology.

[66]  Rolf Gruetter,et al.  Evolution of the Neurochemical Profile after Transient Focal Cerebral Ischemia in the Mouse Brain , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[67]  M. Cuénod,et al.  Redox dysregulation, neurodevelopment, and schizophrenia , 2009, Current Opinion in Neurobiology.

[68]  C. Yasuda,et al.  A combined voxel-based morphometry and 1H-MRS study in patients with Friedreich’s ataxia , 2009, Journal of Neurology.

[69]  Sylvia Notenboom,et al.  Glutathione dysregulation and the etiology and progression of human diseases , 2009, Biological chemistry.

[70]  M. Bastin,et al.  Associations Between Diffusion and Perfusion Parameters, N-Acetyl Aspartate, and Lactate in Acute Ischemic Stroke , 2009, Stroke.

[71]  Masafumi Harada,et al.  Metabolite changes and gender differences in schizophrenia using 3-Tesla proton magnetic resonance spectroscopy (1H-MRS) , 2009, Schizophrenia Research.

[72]  P. Jakob,et al.  Quantitative in vivo 1H spectroscopic imaging of metabolites in the early postnatal mouse brain at 17.6 T , 2009, Magnetic Resonance Materials in Physics, Biology and Medicine.

[73]  Wietske van der Zwaag,et al.  In vivo measurement of glycine with short echo-time 1H MRS in human brain at 7 T , 2009, Magnetic Resonance Materials in Physics, Biology and Medicine.

[74]  F. Cendes,et al.  Axonal Dysfunction in the Deep White Matter in Machado‐Joseph Disease , 2009, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[75]  W. Kaufmann,et al.  Brain metabolism in rett syndrome: Age, clinical, and genotype correlations , 2009, Annals of neurology.

[76]  M. Beal,et al.  Multinuclear Magnetic Resonance Spectroscopy for in Vivo Assessment of Mitochondrial Dysfunction in Parkinson's Disease , 2008, Annals of the New York Academy of Sciences.

[77]  Ramesh C. Gupta,et al.  Taurine as Drug and Functional Food Component , 2008 .

[78]  E Moser,et al.  Metabolic changes in the normal ageing brain: consistent findings from short and long echo time proton spectroscopy. , 2008, European journal of radiology.

[79]  Rolf Gruetter,et al.  1H NMR spectroscopy of rat brain in vivo at 14.1Tesla: improvements in quantification of the neurochemical profile. , 2008, Journal of magnetic resonance.

[80]  H. Urbach,et al.  Combined 3T Diffusion Tensor Tractography and 1H-MR Spectroscopy in Motor Neuron Disease , 2008, American Journal of Neuroradiology.

[81]  R. Gruetter,et al.  In vivo 1H NMR measurement of glycine in rat brain at 9.4 T at short echo time , 2008, Magnetic resonance in medicine.

[82]  Ulf Norinder,et al.  Age related changes in brain metabolites observed by 1H MRS in APP/PS1 mice , 2008, Neurobiology of Aging.

[83]  Daniel Marek,et al.  Performance of a 200‐MHz cryogenic RF probe designed for MRI and MRS of the murine brain , 2008, Magnetic resonance in medicine.

[84]  F. Durif,et al.  Metabolic changes detected by proton magnetic resonance spectroscopy in vivo and in vitro in a murin model of Parkinson’s disease, the MPTP‐intoxicated mouse , 2008, Journal of neurochemistry.

[85]  O. Okonkwo,et al.  Reduced brain glutamate in patients with Parkinson's disease , 2008, NMR in biomedicine.

[86]  Rolf Gruetter,et al.  Proton T2 relaxation time of J‐coupled cerebral metabolites in rat brain at 9.4 T , 2008, NMR in biomedicine.

[87]  C Arús,et al.  Perturbation of mouse glioma MRS pattern by induced acute hyperglycemia , 2008, NMR in biomedicine.

[88]  Steen Moeller,et al.  A geometrically adjustable 16‐channel transmit/receive transmission line array for improved RF efficiency and parallel imaging performance at 7 Tesla , 2008, Magnetic resonance in medicine.

[89]  Peter Boesiger,et al.  SELOVS: Brain MRSI localization based on highly selective T1‐ and B1‐insensitive outer‐volume suppression at 3T , 2008, Magnetic resonance in medicine.

[90]  Rolf Gruetter,et al.  Quantitative proton spectroscopic imaging of the neurochemical profile in rat brain with microliter resolution at ultra‐short echo times , 2008, Magnetic resonance in medicine.

[91]  H. Poulsen,et al.  Vitamin C deficiency in weanling guinea pigs: differential expression of oxidative stress and DNA repair in liver and brain , 2007, British Journal of Nutrition.

[92]  K. Kantarci.  1H magnetic resonance spectroscopy in dementia. , 2007, The British journal of radiology.

[93]  M. McKenna.  The glutamate‐glutamine cycle is not stoichiometric: Fates of glutamate in brain , 2007, Journal of neuroscience research.

[94]  M. Tosetti,et al.  Influences of dopaminergic treatment on motor cortex in Parkinson disease: A MRI/MRS study , 2007, Movement disorders : official journal of the Movement Disorder Society.

[95]  Susan M. Chang,et al.  Three‐dimensional J‐resolved H‐1 magnetic resonance spectroscopic imaging of volunteers and patients with brain tumors at 3T , 2007, Magnetic resonance in medicine.

[96]  Clifford R. Jack,et al.  Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease , 2007, Neurobiology of Aging.

[97]  O. Girard,et al.  Technical aspects: development, manufacture and installation of a cryo-cooled HTS coil system for high-resolution in-vivo imaging of the mouse at 1.5 T. , 2007, Methods.

[98]  K. Uğurbil,et al.  Sustained Neuronal Activation Raises Oxidative Metabolism to a New Steady-State Level: Evidence from 1H NMR Spectroscopy in the Human Visual Cortex , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[99]  E. Weeber,et al.  Ascorbate transport by primary cultured neurons and its role in neuronal function and protection against excitotoxicity , 2007, Journal of neuroscience research.

[100]  R. Gruetter,et al.  Perinatal Iron Deficiency Predisposes the Developing Rat Hippocampus to Greater Injury from Mild to Moderate Hypoxia—Ischemia , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[101]  Rolf Gruetter,et al.  Neurochemical changes in Huntington R6/2 mouse striatum detected by in vivo1H NMR spectroscopy , 2007, Journal of neurochemistry.

[102]  S. Felber,et al.  Differentiation of SCA2 from MSA‐C using proton magnetic resonance spectroscopic imaging , 2007, Journal of magnetic resonance imaging : JMRI.

[103]  H. Heinze,et al.  Metabolic progression markers of neurodegeneration in the transgenic G93A‐SOD1 mouse model of amyotrophic lateral sclerosis , 2007, The European journal of neuroscience.

[104]  R. Camicioli,et al.  Magnetic resonance spectroscopic evidence for presupplementary motor area neuronal dysfunction in Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[105]  Clifford R Jack,et al.  Magnetic Resonance Imaging of Alzheimer's Pathology in the Brains of Living Transgenic Mice: A New Tool in Alzheimer's Disease Research , 2007, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[106]  Franklyn A. Howe,et al.  The clinical value of proton magnetic resonance spectroscopy in adult brain tumours. , 2007, Clinical radiology.

[107]  Rolf Gruetter,et al.  Localized short‐echo‐time proton MR spectroscopy with full signal‐intensity acquisition , 2006, Magnetic resonance in medicine.

[108]  M. Beal,et al.  Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases , 2006, Nature.

[109]  R. Gruetter,et al.  Effect of chronic hypoglycaemia on glucose concentration and glycogen content in rat brain: a localized 13C NMR study , 2006, Journal of neurochemistry.

[110]  Jun Shen,et al.  Increased oxygen consumption in the somatosensory cortex of α-chloralose anesthetized rats during forepaw stimulation determined using MRS at 11.7 Tesla , 2006, NeuroImage.

[111]  Terence W Nixon,et al.  High magnetic field water and metabolite proton T1 and T2 relaxation in rat brain in vivo , 2006, Magnetic resonance in medicine.

[112]  A. Haley,et al.  Increased glucose concentration in the hippocampus in early Alzheimer's disease following oral glucose ingestion. , 2006, Magnetic resonance imaging.

[113]  F. Kirkham,et al.  Hypoxic adaptation during development: relation to pattern of neurological presentation and cognitive disability. , 2006, Developmental science.

[114]  Wingchi E Kwok,et al.  In vivo MRI using liquid nitrogen cooled phased array coil at 3.0 T. , 2006, Magnetic resonance imaging.

[115]  Wen-Jang Chu,et al.  Robust fully automated shimming of the human brain for high‐field 1H spectroscopic imaging , 2006, Magnetic resonance in medicine.

[116]  Heinrich Betz,et al.  Glycine receptors: recent insights into their structural organization and functional diversity , 2006, Journal of neurochemistry.

[117]  Elias R Melhem,et al.  Amyotrophic lateral sclerosis: diffusion-tensor and chemical shift MR imaging at 3.0 T. , 2006, Radiology.

[118]  A. W. Simonetti,et al.  Development of a decision support system for diagnosis and grading of brain tumours using in vivo magnetic resonance single voxel spectra , 2006, NMR in biomedicine.

[119]  Leif Hertz,et al.  Glutamate, a neurotransmitter—And so much more A synopsis of Wierzba III , 2006, Neurochemistry International.

[120]  R. Gruetter,et al.  Quantification of vitamin C in the rat brain in vivo using short echo‐time 1H MRS , 2006, Magnetic resonance in medicine.

[121]  Douglas L. Arnold,et al.  Rapid improvement in cortical neuronal integrity in amyotrophic lateral sclerosis detected by proton magnetic resonance spectroscopic imaging , 2006, Journal of Neurology.

[122]  Y. Mitsumoto,et al.  1H MRS identifies lactate rise in the striatum of MPTP‐treated C57BL/6 mice , 2006 .

[123]  Rolf Gruetter,et al.  Proton MRS of the unilateral substantia nigra in the human brain at 4 tesla: Detection of high GABA concentrations , 2006, Magnetic resonance in medicine.

[124]  R. Cunha,et al.  Modification of adenosine A1 and A2A receptor density in the hippocampus of streptozotocin-induced diabetic rats , 2006, Neurochemistry International.

[125]  Hoby P Hetherington,et al.  Fully automated shim mapping method for spectroscopic imaging of the mouse brain at 9.4 T , 2006, Magnetic resonance in medicine.

[126]  C. Grillo,et al.  Immunocytochemical analysis of synaptic proteins provides new insights into diabetes-mediated plasticity in the rat hippocampus , 2005, Neuroscience.

[127]  Ravinder Reddy,et al.  Altered Glutathione Redox State in Schizophrenia , 2005, Disease markers.

[128]  A. Schousboe,et al.  Taurine Interaction with Neurotransmitter Receptors in the CNS: An Update , 2005, Neurochemical Research.

[129]  Steen Moeller,et al.  B1 destructive interferences and spatial phase patterns at 7 T with a head transceiver array coil , 2005, Magnetic resonance in medicine.

[130]  K. Uğurbil,et al.  Validation of glutathione quantitation from STEAM spectra against edited 1H NMR spectroscopy at 4T: application to schizophrenia , 2005, Magnetic Resonance Materials in Physics, Biology and Medicine.

[131]  Jun Shen,et al.  Metabolic alterations in focally activated primary somatosensory cortex of α-chloralose-anesthetized rats measured by 1H MRS at 11.7 T , 2005, NeuroImage.

[132]  O. Andreassen,et al.  Effects of CAG repeat length, HTT protein length and protein context on cerebral metabolism measured using magnetic resonance spectroscopy in transgenic mouse models of Huntington's disease , 2005, Journal of neurochemistry.

[133]  G. Johnson,et al.  Increased glutathione levels in cortical and striatal mitochondria of the R6/2 Huntington's disease mouse model , 2005, Neuroscience Letters.

[134]  Clifford R Jack,et al.  Monitoring disease progression in transgenic mouse models of Alzheimer's disease with proton magnetic resonance spectroscopy. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[135]  C. Bard,et al.  1H magnetic resonance spectroscopy of autosomal ataxias , 2005, Brain Research.

[136]  C. Zwingmann,et al.  An update on the role of brain glutamine synthesis and its relation to cell-specific energy metabolism in the hyperammonemic brain: Further studies using NMR spectroscopy , 2005, Neurochemistry International.

[137]  R. Gruetter,et al.  In vivo effect of chronic hypoxia on the neurochemical profile of the developing rat hippocampus. , 2005, Brain research. Developmental brain research.

[138]  R. Gonzalez,et al.  Relationships between astrogliosis and 1H MR spectroscopic measures of brain choline/creatine and myo-inositol/creatine in a primate model. , 2005, AJNR. American journal of neuroradiology.

[139]  Jun Shen,et al.  Selective homonuclear Hartmann–Hahn transfer method for in vivo spectral editing in the human brain , 2005, Magnetic resonance in medicine.

[140]  Mariano G. Uberti,et al.  Quantitative 1H Magnetic Resonance Spectroscopic Imaging Determines Therapeutic Immunization Efficacy in an Animal Model of Parkinson's Disease , 2005, The Journal of Neuroscience.

[141]  P. Börnert,et al.  Basic considerations on the impact of the coil array on the performance of Transmit SENSE , 2005, Magnetic Resonance Materials in Physics, Biology and Medicine.

[142]  E G Tangalos,et al.  1H MR spectroscopy in common dementias , 2004, Neurology.

[143]  J. Lynch,et al.  Molecular structure and function of the glycine receptor chloride channel. , 2004, Physiological reviews.

[144]  M. van der Graaf,et al.  Metabolic profile of the hippocampus of Zucker Diabetic Fatty rats assessed by in vivo 1H magnetic resonance spectroscopy , 2004, NMR in biomedicine.

[145]  Peter Andersen,et al.  Highly resolved in vivo 1H NMR spectroscopy of the mouse brain at 9.4 T , 2004, Magnetic resonance in medicine.

[146]  John H Krystal,et al.  Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. , 2004, Archives of general psychiatry.

[147]  Ji-Kyung Choi,et al.  Magnetic resonance spectroscopic analysis of Alzheimer's disease mouse brain that express mutant human APP shows altered neurochemical profile , 2004, Brain Research.

[148]  Deborah A. Yurgelun-Todd,et al.  Frontal lobe GABA levels in cocaine dependence: a two-dimensional, J-resolved magnetic resonance spectroscopy study , 2004, Psychiatry Research: Neuroimaging.

[149]  S. Chantal,et al.  Similar 1H magnetic resonance spectroscopic metabolic pattern in the medial temporal lobes of patients with mild cognitive impairment and Alzheimer disease , 2004, Brain Research.

[150]  A. Eschalier,et al.  Brain GABA editing by localized in vivo 1H magnetic resonance spectroscopy , 2004, NMR in biomedicine.

[151]  A. Nehlig.  Brain uptake and metabolism of ketone bodies in animal models. , 2004, Prostaglandins, leukotrienes, and essential fatty acids.

[152]  R. Gruetter,et al.  1H NMR detection of vitamin C in human brain in vivo , 2004, Magnetic resonance in medicine.

[153]  Chen Chang,et al.  Magnetic resonance imaging and spectroscopy in assessing 3-nitropropionic acid-induced brain lesions: an animal model of Huntington’s disease , 2004, Progress in Neurobiology.

[154]  S. Shankar,et al.  Pyruvate: An in vivo marker of cestodal infestation of the human brain on proton MR spectroscopy , 2003, Journal of magnetic resonance imaging : JMRI.

[155]  C. Craciunescu,et al.  Choline availability during embryonic development alters progenitor cell mitosis in developing mouse hippocampus. , 2003, The Journal of nutrition.

[156]  Rolf Gruetter,et al.  Localized in vivo 13C NMR spectroscopy of the brain , 2003, NMR in biomedicine.

[157]  J. Schölmerich,et al.  Alterations of cerebral metabolism in patients with diabetes mellitus studied by proton magnetic resonance spectroscopy. , 2003, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[158]  R. Gruetter,et al.  Perinatal iron deficiency alters the neurochemical profile of the developing rat hippocampus. , 2003, The Journal of nutrition.

[159]  S. Pundik,et al.  Changing Metabolic and Energy Profiles in Fetal, Neonatal, and Adult Rat Brain , 2003, Metabolic Brain Disease.

[160]  E. Palacios-Prü,et al.  Prenatal and Postnatal Contents of Amino Acid Neurotransmitters in Mouse Parietal Cortex , 2003, Developmental Neuroscience.

[161]  Ferenc A Jolesz,et al.  Superconducting RF coils for clinical MR imaging at low field. , 2003, Academic radiology.

[162]  L. Rorke,et al.  In vivo pyruvate detected by MR spectroscopy in neonatal pyruvate dehydrogenase deficiency. , 2003, AJNR. American journal of neuroradiology.

[163]  Rolf Gruetter,et al.  Measurement of reduced glutathione (GSH) in human brain using LCModel analysis of difference‐edited spectra , 2003, Magnetic resonance in medicine.

[164]  Rolf Gruetter,et al.  Developmental and regional changes in the neurochemical profile of the rat brain determined by in vivo 1H NMR spectroscopy , 2003, Magnetic resonance in medicine.

[165]  Morris H. Baslow,et al.  N-Acetylaspartate in the Vertebrate Brain: Metabolism and Function , 2003, Neurochemical Research.

[166]  Franklyn A Howe,et al.  1H MR spectroscopy of brain tumours and masses , 2003, NMR in biomedicine.

[167]  John S Duncan,et al.  A Proton Magnetic Resonance Spectroscopy Study of Metabolites in the Occipital Lobes in Epilepsy , 2003, Epilepsia.

[168]  D. Arnold,et al.  Gabapentin therapy for amyotrophic lateral sclerosis: lack of improvement in neuronal integrity shown by MR spectroscopy. , 2003, AJNR. American journal of neuroradiology.

[169]  M. Tuzcu,et al.  Increase of glial fibrillary acidic protein and S-100B in hippocampus and cortex of diabetic rats: effects of vitamin E. , 2003, European journal of pharmacology.

[170]  M. Podell,et al.  Proton magnetic resonance imaging and spectroscopy identify metabolic changes in the striatum in the MPTP feline model of parkinsonism , 2003, Experimental Neurology.

[171]  N. Kowall,et al.  Choline Availability During Embryonic Development Alters the Localization of Calretinin in Developing and Aging Mouse Hippocampus , 2003, Nutritional neuroscience.

[172]  P. Börnert,et al.  Transmit SENSE , 2003, Magnetic resonance in medicine.

[173]  A. Lima,et al.  Increased astrocyte reactivity in the hippocampus of murine models of type 1 diabetes: the nonobese diabetic (NOD) and streptozotocin-treated mice , 2002, Brain Research.

[174]  À. Rovira,et al.  1H Magnetic Resonance in the Study of Hepatic Encephalopathy in Humans , 2002, Metabolic Brain Disease.

[175]  G. Dienel,et al.  Generalized Sensory Stimulation of Conscious Rats Increases Labeling of Oxidative Pathways of Glucose Metabolism When the Brain Glucose–Oxygen Uptake Ratio Rises , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[176]  D. Jacobowitz,et al.  Aspartoacylase is restricted primarily to myelin synthesizing cells in the CNS: therapeutic implications for Canavan disease. , 2002, Brain research. Molecular brain research.

[177]  R. Gruetter,et al.  Effect of Deep Pentobarbital Anesthesia on Neurotransmitter Metabolism in Vivo: On the Correlation of Total Glucose Consumption with Glutamatergic Action , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[178]  S. Chantal,et al.  Correlation of regional proton magnetic resonance spectroscopic metabolic changes with cognitive deficits in mild Alzheimer disease. , 2002, Archives of neurology.

[179]  Mario Mascalchi,et al.  Proton MR spectroscopy of the cerebellum and pons in patients with degenerative ataxia. , 2002, Radiology.

[180]  Rolf Gruetter,et al.  Direct in vivo measurement of human cerebral GABA concentration using MEGA‐editing at 7 Tesla , 2002, Magnetic resonance in medicine.

[181]  N. Schuff,et al.  Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD , 2002, Neurology.

[182]  N. Schuff,et al.  Early detection and longitudinal changes in amyotrophic lateral sclerosis by 1H MRSI , 2002 .

[183]  H. Lanfermann,et al.  Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions , 2002, Neuroradiology.

[184]  J. Lykkesfeldt.  Increased Oxidative Damage in Vitamin C Deficiency is Accompanied by Induction of Ascorbic Acid Recycling Capacity in Young But Not Mature Guinea Pigs , 2002, Free radical research.

[185]  L DelaBarre,et al.  The return of the frequency sweep: designing adiabatic pulses for contemporary NMR. , 2001, Journal of magnetic resonance.

[186]  M. Chesselet,et al.  Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice. , 2001, Journal of neurophysiology.

[187]  C. Clarke,et al.  Systematic review of proton magnetic resonance spectroscopy of the striatum in parkinsonian syndromes , 2001, European journal of neurology.

[188]  D. Rothman,et al.  Measurement of β‐hydroxybutyrate in acute hyperketonemia in human brain , 2001 .

[189]  R. Gruetter,et al.  The effect of insulin on in vivo cerebral glucose concentrations and rates of glucose transport/metabolism in humans. , 2001, Diabetes.

[190]  G. E. Alexander,et al.  Brain metabolite concentration and dementia severity in Alzheimer’s disease , 2001, Neurology.

[191]  R. Ledeen,et al.  Intraneuronal N‐acetylaspartate supplies acetyl groups for myelin lipid synthesis: evidence for myelin‐associated aspartoacylase , 2001, Journal of neurochemistry.

[192]  P. Styles,et al.  Hypo‐osmotic swelling‐activated release of organic osmolytes in brain slices: implications for brain oedema in vivo , 2001, Journal of neurochemistry.

[193]  G F Mason,et al.  Reductions in occipital cortex GABA levels in panic disorder detected with 1h-magnetic resonance spectroscopy. , 2001, Archives of general psychiatry.

[194]  D. Graveron-Demilly,et al.  Java-based graphical user interface for the MRUI quantitation package , 2001, Magnetic Resonance Materials in Physics, Biology and Medicine.

[195]  M W Weiner,et al.  Region and tissue differences of metabolites in normally aged brain using multislice 1H magnetic resonance spectroscopic imaging , 2001, Magnetic resonance in medicine.

[196]  H. Schild,et al.  Proton magnetic resonance spectroscopy of the motor cortex in 70 patients with amyotrophic lateral sclerosis. , 2001, Archives of neurology.

[197]  S. Bluml,et al.  Magnetic resonance spectroscopy of the human brain , 2001, The Anatomical record.

[198]  O. Andreassen,et al.  Increases in cortical glutamate concentrations in transgenic amyotrophic lateral sclerosis mice are attenuated by creatine supplementation , 2001, Journal of neurochemistry.

[199]  W. Poewe,et al.  Proton magnetic resonance spectroscopic imaging reveals differences in spinocerebellar ataxia types 2 and 6 , 2001, Journal of magnetic resonance imaging : JMRI.

[200]  R. Tarducci,et al.  Magnetic resonance imaging and 1H-magnetic resonance spectroscopy in amyotrophic lateral sclerosis , 2001, Neuroradiology.

[201]  K. Uğurbil,et al.  Study of tricarboxylic acid cycle flux changes in human visual cortex during hemifield visual stimulation using 1H‐{13C} MRS and fMRI , 2001, Magnetic resonance in medicine.

[202]  M. Tosetti,et al.  Proton magnetic resonance spectroscopy (1H-MRS) of motor cortex and basal ganglia in de novo Parkinson's disease patients , 2001, Neurological Sciences.

[203]  T. Fitzgibbon,et al.  Regional distribution and pharmacological characteristics of [3H]N-acetyl-aspartyl-glutamate (NAAG) binding sites in rat brain , 2001, Neurochemistry International.

[204]  E. D. Muse,et al.  Parameters related to lipid metabolism as markers of myelination in mouse brain , 2001, Journal of neurochemistry.

[205]  J. Neale,et al.  NAAG inhibits KCl‐induced [3H]‐GABA release via mGluR3, cAMP, PKA and L‐type calcium conductance , 2001, The European journal of neuroscience.

[206]  R. Dringen,et al.  Metabolism and functions of glutathione in brain , 2000, Progress in Neurobiology.

[207]  P Boesiger,et al.  Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo , 2000, The European journal of neuroscience.

[208]  F Träber,et al.  Proton MR spectroscopy detects a relative decrease of N-acetylaspartate in the medial temporal lobe of patients with AD , 2000, Neurology.

[209]  P. Barber,et al.  Combined 1H MR spectroscopy and diffusion-weighted MRI improves the prediction of stroke outcome , 2000, Neurology.

[210]  M. Rice.  Ascorbate regulation and its neuroprotective role in the brain , 2000, Trends in Neurosciences.

[211]  O. Andreassen,et al.  Nonlinear Decrease over Time in N‐Acetyl Aspartate Levels in the Absence of Neuronal Loss and Increases in Glutamine and Glucose in Transgenic Huntington's Disease Mice , 2000, Journal of neurochemistry.

[212]  T E Conturo,et al.  Differences between gray matter and white matter water diffusion in stroke: diffusion-tensor MR imaging in 12 patients. , 2000, Radiology.

[213]  R Gruetter,et al.  Field mapping without reference scan using asymmetric echo‐planar techniques , 2000, Magnetic resonance in medicine.

[214]  Felix W. Wehrli,et al.  In vivo MR micro imaging with conventional radiofrequency coils cooled to 77°K , 2000 .

[215]  M. Galarreta,et al.  Taurine-induced synaptic potentiation: role of calcium and interaction with LTP , 2000, Neuropharmacology.

[216]  Jullie W Pan,et al.  Linear projection method for automatic slice shimming , 1999, Magnetic resonance in medicine.

[217]  R Gruetter,et al.  Toward an in vivo neurochemical profile: quantification of 18 metabolites in short-echo-time (1)H NMR spectra of the rat brain. , 1999, Journal of magnetic resonance.

[218]  A. Wyrwicz,et al.  In vitro proton and phosphorus NMR spectroscopic analysis of murine (C57Bl/6J) brain development , 1999, NMR in biomedicine.

[219]  S. Blüml,et al.  Developmental changes in choline‐ and ethanolamine‐containing compounds measured with proton‐decoupled 31P MRS in in vivo human brain , 1999, Magnetic resonance in medicine.

[220]  J. Frahm,et al.  Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. , 1999, AJNR. American journal of neuroradiology.

[221]  T. Ng,et al.  1H-MRS evidence of neurodegeneration and excess glutamate glutamine in ALS medulla , 1999, Neurology.

[222]  D L Rothman,et al.  Preliminary evidence of low cortical GABA levels in localized 1H-MR spectra of alcohol-dependent and hepatic encephalopathy patients. , 1999, The American journal of psychiatry.

[223]  Norbert Schuff,et al.  Age-related metabolite changes and volume loss in the hippocampus by magnetic resonance spectroscopy and imaging☆ , 1999, Neurobiology of Aging.

[224]  R. Gruetter,et al.  In vivo 1H NMR spectroscopy of rat brain at 1 ms echo time , 1999, Magnetic resonance in medicine.

[225]  D. Brooks,et al.  A Proton Magnetic Resonance Spectroscopy Study of the Striatum and Cerebral Cortex in Parkinson's Disease , 1999, Metabolic Brain Disease.

[226]  D M Doddrell,et al.  A 1H MRS study of probable Alzheimer's disease and normal aging: implications for longitudinal monitoring of dementia progression. , 1999, Magnetic resonance imaging.

[227]  K O Lim,et al.  In vivo spectroscopic quantification of the N‐acetyl moiety, creatine, and choline from large volumes of brain gray and white matter: Effects of normal aging , 1999, Magnetic resonance in medicine.

[228]  K O Lim,et al.  In vivo brain concentrations of N-acetyl compounds, creatine, and choline in Alzheimer disease. , 1999, Archives of general psychiatry.

[229]  R Gruetter,et al.  Lactate turnover in rat glioma measured by in vivo nuclear magnetic resonance spectroscopy. , 1998, Cancer research.

[230]  Bruce G. Jenkins,et al.  Combined PET/MRS brain studies show dynamic and long-term physiological changes in a primate model of Parkinson disease , 1998, Nature Medicine.

[231]  J. Pettegrew,et al.  Metabolic alterations in postmortem Alzheimer’s disease brain are exaggerated by Apo-E4 , 1998, Neurobiology of Aging.

[232]  M. Garwood,et al.  Simultaneous in vivo spectral editing and water suppression , 1998, NMR in biomedicine.

[233]  T. Ng,et al.  Neuronal pathology in the wobbler mouse brain revealed by in vivo proton magnetic resonance spectroscopy and immunocytochemistry , 1998, Neuroreport.

[234]  I. Marshall,et al.  Studies of acute ischemic stroke with proton magnetic resonance spectroscopy: relation between time from onset, neurological deficit, metabolite abnormalities in the infarct, blood flow, and clinical outcome. , 1998, Stroke.

[235]  R. A. Waniewski,et al.  Preferential Utilization of Acetate by Astrocytes Is Attributable to Transport , 1998, The Journal of Neuroscience.

[236]  Stephen Ashwal,et al.  Proton Magnetic Resonance Spectroscopy: An Emerging Technology in Pediatric Neurology Research , 1998, Pediatric Research.

[237]  C Boesch,et al.  Versatile frequency domain fitting using time domain models and prior knowledge , 1998, Magnetic resonance in medicine.

[238]  D. Arnold,et al.  Recovery of N‐acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy , 1998, Neuroreport.

[239]  R Gruetter,et al.  Localized eddy current compensation using quantitative field mapping. , 1998, Journal of magnetic resonance.

[240]  C. Hanstock,et al.  Estimation of brainstem neuronal loss in amyotrophic lateral sclerosis with in vivo proton magnetic resonance spectroscopy , 1998, Neurology.

[241]  K. Uğurbil,et al.  Steady‐State Cerebral Glucose Concentrations and Transport in the Human Brain , 1998, Journal of neurochemistry.

[242]  J. Frahm,et al.  Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS , 1998, Magnetic resonance in medicine.

[243]  S. Huffel,et al.  Improved method for accurate and efficient quantification of MRS data with use of prior knowledge , 1997, Journal of magnetic resonance.

[244]  Anand Rangarajan,et al.  Oxidative Glucose Metabolism in Rat Brain during Single Forepaw Stimulation: A Spatially Localized 1H[13C] Nuclear Magnetic Resonance Study , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[245]  M. Hallett,et al.  Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration. , 1997, Brain : a journal of neurology.

[246]  M. Tsai,et al.  Metabolic alterations produced by 3-nitropropionic acid in rat striata and cultured astrocytes: quantitative in vitro 1H nuclear magnetic resonance spectroscopy and biochemical characterization , 1997, Neuroscience.

[247]  S. Topp,et al.  Quantification of brain metabolites in amyotrophic lateral sclerosis by localized proton magnetic resonance spectroscopy , 1997, Neurology.

[248]  P. Jolles,et al.  Regional metabolic alterations in Alzheimer's disease: an in vitro 1H NMR study of the hippocampus and cerebellum. , 1997, The journals of gerontology. Series A, Biological sciences and medical sciences.

[249]  A. Fink-Jensen,et al.  Transient Elevation of Interstitial N‐Acetylaspartate in Reversible Global Brain Ischemia , 1997, Journal of neurochemistry.

[250]  Y. Kinoshita,et al.  Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy , 1997, NMR in biomedicine.

[251]  G. Biessels,et al.  Place Learning and Hippocampal Synaptic Plasticity in Streptozotocin-Induced Diabetic Rats , 1996, Diabetes.

[252]  F. Hyder,et al.  Increased tricarboxylic acid cycle flux in rat brain during forepaw stimulation detected with 1H[13C]NMR. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[253]  I. Loubinoux,et al.  A One‐Dimensional (Proton and Phosphorus) and Two‐Dimensional (Proton) In Vivo NMR Spectroscopic Study of Reversible Global Cerebral Ischemia , 1996, Journal of neurochemistry.

[254]  B R Rosen,et al.  Non-Invasive Neurochemical Analysis of Focal Excitotoxic Lesions in Models of Neurodegenerative Illness Using Spectroscopic Imaging , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[255]  R. Gruetter,et al.  1H NMR Studies of Glucose Transport in the Human Brain , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[256]  D J Jenden,et al.  In vivo proton magnetic resonance spectroscopy of the normal aging human brain. , 1996, Life sciences.

[257]  A. Kleinschmidt,et al.  Dynamic uncoupling and recoupling of perfusion and oxidative metabolism during focal brain activation in man , 1996, Magnetic resonance in medicine.

[258]  P. Matthews,et al.  Reversible decreases in N‐acetylaspartate after acute brain injury , 1995, Magnetic resonance in medicine.

[259]  J. S. Lund,et al.  Synchronous development of pyramidal neuron dendritic spines and parvalbumin-immunoreactive chandelier neuron axon terminals in layer III of monkey prefrontal cortex , 1995, Neuroscience.

[260]  H. Poptani,et al.  In vivo Proton Magnetic Resonance Spectroscopy in a Case of Intracranial Hydatid Cyst , 1995, Neurology.

[261]  T. Yuasa,et al.  Lactate rise in the basal ganglia accompanying finger movements: a localized1H-MRS study , 1995, Brain Research.

[262]  R. Vannucci,et al.  Glucose transport in developing rat brain: Glucose transporter proteins, rate constants and cerebral glucose utilization , 1994, Molecular and Cellular Biochemistry.

[263]  P. Magistretti,et al.  Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[264]  D. Arnold,et al.  Detection of cortical neuron loss in motor neuron disease by proton magnetic resonance spectroscopic imaging in vivo , 1994, Neurology.

[265]  S. Skaper,et al.  N‐Acetylaspartylglutamate Selectively Inhibits Neuronal Responses to N‐Methyl‐d‐Aspartic Acid In Vitro , 1994, Journal of neurochemistry.

[266]  S. Wray,et al.  Developmental and gestational changes of phosphoethanolamine and taurine in rat brain, striated and smooth muscle , 1994, Experimental physiology.

[267]  G. Rebec,et al.  A vitamin as neuromodulator: Ascorbate release into the extracellular fluid of the brain regulates dopaminergic and glutamatergic transmission , 1994, Progress in Neurobiology.

[268]  G. Fein,et al.  Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging , 1994, Annals of neurology.

[269]  T. Olsen,et al.  Long‐term Follow‐up of Cerebral Infarction Patients With Proton Magnetic Resonance Spectroscopy , 1994, Stroke.

[270]  S. Provencher.  Estimation of metabolite concentrations from localized in vivo proton NMR spectra , 1993, Magnetic resonance in medicine.

[271]  R G Shulman,et al.  Localized 1H NMR measurement of glucose consumption in the human brain during visual stimulation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[272]  Roland Kreis,et al.  Development of the human brain: In vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy , 1993, Magnetic resonance in medicine.

[273]  R Gruetter,et al.  Automatic, localized in Vivo adjustment of all first‐and second‐order shim coils , 1993, Magnetic resonance in medicine.

[274]  J. Neale,et al.  N-Acetylaspartylglutamate catabolism is achieved by an enzyme on the cell surface of neurons and glia , 1993, Neuropeptides.

[275]  B D Ross,et al.  Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy. , 1993, Radiology.

[276]  T. Olsen,et al.  Early Time Course of N‐Acetylaspartate, Creatine and Phosphocreatine, and Compounds Containing Choline in the Brain After Acute Stroke: A Proton Magnetic Resonance Spectroscopy Study , 1992, Stroke.

[277]  H. Trachtman,et al.  Cerebral Taurine Transport Is Increased During Streptozocin-Induced Diabetes in Rats , 1992, Diabetes.

[278]  R. Kreis,et al.  Cerebral metabolic disturbances in patients with subacute and chronic diabetes mellitus: detection with proton MR spectroscopy. , 1992, Radiology.

[279]  G. Fein,et al.  Effect of Photic Stimulation on Human Visual Cortex Lactate and Phosphates Using 1H and 31P Magnetic Resonance Spectroscopy , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[280]  R G Shulman,et al.  NMR Determination of Intracerebral Glucose Concentration and Transport Kinetics in Rat Brain , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[281]  B. Rosen,et al.  1‐Methyl‐4‐Phenylpyridinium Produces Excitotoxic Lesions in Rat Striatum as a Result of Impairment of Oxidative Metabolism , 1992, Journal of neurochemistry.

[282]  Jens Frahm,et al.  Decrease of glucose in the human visual cortex during photic stimulation , 1992, Magnetic resonance in medicine.

[283]  J. Growdon,et al.  Evidence for a membrane defect in Alzheimer disease brain. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[284]  Rolf Gruetter,et al.  Fast, noniterative shimming of spatially localized signals. In vivo analysis of the magnetic field along axes , 1992 .

[285]  Michael Garwood,et al.  Symmetric pulses to induce arbitrary flip angles with compensation for rf inhomogeneity and resonance offsets , 1991 .

[286]  C. Boesch,et al.  Temporal and spatial analysis of fields generated by eddy currents in superconducting magnets: Optimization of corrections and quantitative characterization of magnet/gradient systems , 1991, Magnetic resonance in medicine.

[287]  R. Shulman,et al.  Lactate rise detected by 1H NMR in human visual cortex during physiologic stimulation. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[288]  P. Manos,et al.  Creatine Kinase Activity in Postnatal Rat Brain Development and in Cultured Neurons, Astrocytes, and Oligodendrocytes , 1991, Journal of neurochemistry.

[289]  G. Glover,et al.  Rapid in vivo proton shimming , 1991, Magnetic resonance in medicine.

[290]  B D Ross,et al.  Localized 1H NMR spectroscopy in patients with chronic hepatic encephalopathy. Analysis of changes in cerebral glutamine, choline and inositols , 1991, NMR in biomedicine.

[291]  R. Bowtell,et al.  Gradient coil design using active magnetic screening , 1991, Magnetic resonance in medicine.

[292]  P. Jehenson,et al.  Analytical method for the compensation of eddy-current effects induced by pulsed magnetic field gradients in NMR systems , 1990 .

[293]  Anthonie Hendrik Bergman,et al.  Optimization of eddy-current compensation☆ , 1990 .

[294]  S. Posse,et al.  Brain development:1H magnetic resonance spectroscopy of rat brain extracts compared with chromatographic methods , 1990, Neurochemical Research.

[295]  B. Künnecke,et al.  Cerebral metabolism of [1,2-13C2]acetate as detected by in vivo and in vitro 13C NMR. , 1990, The Journal of biological chemistry.

[296]  W M Bovée,et al.  Improved quantification of in vivo1H NMR spectra by optimization of signal acquisition and processing and by incorporation of prior knowledge into the spectral fitting , 1990, Magnetic resonance in medicine.

[297]  F. Palmer,et al.  Differences in the metabolism of inositol and phosphoinositides by cultured cells of neuronal and glial origin. , 1989, Biochimica et biophysica acta.

[298]  J. Frahm,et al.  Cerebral metabolism in man after acute stroke: New observations using localized proton NMR spectroscopy , 1989, Magnetic resonance in medicine.

[299]  R. Ordidge,et al.  Snap-shot magnetic resonance imaging at 0.1 T using double-screened gradients , 1988 .

[300]  F. Abildgaard,et al.  Quantitative analysis of complicated nonideal fourier transform NMR spectra , 1988 .

[301]  B. Ross,et al.  Carbohydrate metabolism of the rat c6 glioma. an in vivo 13c and in vitro 1h magnetic resonance spectroscopy study , 1988, NMR in biomedicine.

[302]  P. Luyten,et al.  Accurate quantification of in vivo 31P NMR signals using the variable projection method and prior knowledge , 1988, Magnetic resonance in medicine.

[303]  P. Bottomley.  Spatial Localization in NMR Spectroscopy in Vivo , 1987, Annals of the New York Academy of Sciences.

[304]  R. Bunge,et al.  Differentiation of axon-related Schwann cells in vitro. I. Ascorbic acid regulates basal lamina assembly and myelin formation , 1987, The Journal of cell biology.

[305]  M. Mayer,et al.  High concentrations of N-acetylaspartylglutamate (NAAG) selectively activate NMDA receptors on mouse spinal cord neurons in cell culture , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[306]  P. Mansfield,et al.  Active magnetic screening of gradient coils in NMR imaging , 1986 .

[307]  Roger J. Ordidge,et al.  Image-selected in Vivo spectroscopy (ISIS). A new technique for spatially selective nmr spectroscopy , 1986 .

[308]  L. Bolinger,et al.  Phosphorylethanolamine ‐ the major constituent of the phosphomonoester peak observed by 31P‐NMR on developing dog brain , 1984, FEBS letters.

[309]  J. Coyle,et al.  Ontogenesis of N-acetyl-aspartate and N-acetyl-aspartyl-glutamate in rat brain. , 1984, Brain research.

[310]  K. Uğurbil,et al.  NMR chemical shift imaging in three dimensions. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[311]  J. Skerritt,et al.  Postnatal development of GABA binding sites and their endogenous inhibitors in rat brain. , 1982, Developmental neuroscience.

[312]  D I Hoult,et al.  The signal-to-noise ratio of the nuclear magnetic resonance experiment. 1976. , 1976, Journal of magnetic resonance.

[313]  E. Costantino-Ceccarini,et al.  Biosynthesis of brain sphingolipids and myelin accumulation in the mouse , 1972, Lipids.

[314]  W. C. McMurray,et al.  THE METABOLISM OF AMINO ACIDS IN DEVELOPING RAT BRAIN * , 1967, Journal of neurochemistry.

[315]  F. Yatsu,et al.  ACETATE METABOLISM IN THE NERVOUS SYSTEM. N‐ACETYL‐l‐ASPARTIC ACID AND THE BIOSYNTHESIS OF BRAIN LIPIDS * , 1966, Journal of neurochemistry.

[316]  K. Behar,et al.  Quantification of high-resolution (1)H NMR spectra from rat brain extracts. , 2011, Analytical chemistry.

[317]  R. Gruetter,et al.  Early metabolic changes in the amyotrophic lateral sclerosis SOD1 mouse brain are revealed using 1H MRS rather than CASL and 18FDG PET , 2011 .

[318]  G. Jahng,et al.  Assessment of metabolic changes in the striatum of a MPTP-intoxicated canine model: in vivo ¹H-MRS study of an animal model for Parkinson's disease. , 2011, Magnetic resonance imaging.

[319]  R. Gruetter,et al.  evelopmental and metabolic brain alterations in rats exposed to bisphenol during gestation and lactation , 2010 .

[320]  R. Gruetter,et al.  Effect of long-term caffeine consumption on glucose transport and osmolarity alterations in the hippocampus of STZ-induced and Goto-Kakizaki diabetic rats: in vivo 1H MRS study at 9.4 T , 2009 .

[321]  J J Mallet,et al.  Regional differences and metabolic changes in normal aging of the human brain: proton MR spectroscopic imaging study. , 2001, AJNR. American journal of neuroradiology.

[322]  W. E. Davies,et al.  Taurine fluxes in insulin dependent diabetes mellitus and rehydration in streptozotocin treated rats. , 2000, Advances in experimental medicine and biology.

[323]  J. Klein.  Membrane breakdown in acute and chronic neurodegeneration: focus on choline-containing phospholipids , 2000, Journal of Neural Transmission.

[324]  V. L. Doyle,et al.  Middle Cerebral Artery Territory Infarction Spectroscopy and Initial Infarct Volume by MRI Predicts Outcome in Patients With Acetyl Aspartate Concentration by Magnetic Resonance N-Measurement of Initial , 1999 .

[325]  P. Morell,et al.  Myelin Formation, Structure and Biochemistry , 1999 .

[326]  A. Kriegstein,et al.  Nonsynaptic Glycine Receptor Activation during Early Neocortical Development , 1998, Neuron.

[327]  R. A. Graaf.  In vivo NMR spectroscopy , 1998 .

[328]  D. Leibfritz,et al.  Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. , 1993, Developmental neuroscience.

[329]  N. Herschkowitz,et al.  N-acetyl-L-aspartate is a major source of acetyl groups for lipid synthesis during rat brain development. , 1991, Developmental neuroscience.

[330]  M. Ugarte,et al.  Glycine metabolism and glycine synthase activity during the postnatal development of rat brain. , 1980, Developmental neuroscience.

[331]  Rolf Gruetter,et al.  Snapshot Gradient-recalled Echo-planar Images of Rat Brains at Long Echo Time at 9.4 T , 2022 .